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DNA PHOTOLITHOGRAPHY WITH 
CINNAMATE CROSSLINKERS 
CROSS REFERENCE TO RELATED 
APPLICATIONS 
This application claims priority to U.S. Provisional Appli-
cation No. 61/770,938 filed Feb. 28, 2013, herein incorpo-
rated by reference in its entirety. 
STATEMENT OF GOVERNMENT-SPONSORED 
RESEARCH 
This invention was made with United States government 
support awarded by the following agencies: MRSEC Pro-
gram of the National Science Foundation (Award No. DMR-
0820341), NASA (Award No. NNX08AK04G), the National 
Institute of General Medical Sciences (GM-29554), the 
National Science Foundation (CTS-0608889 and CCF-
0726378), the Army Research Office (48681-EL and 
W911NF-07-1-0439), and the Office of Naval Research 
(N000140910181 and N000140911118). The United States 
government may have certain rights in the invention. 
SEQUENCE LISTING 
The instant application contains a Sequence Listing which 
has been submitted electronically in ASCII format and is 
hereby incorporated by reference in its entirety. Said ASCII 
copy, created on May 16, 2014, is named 046434-
0442_SL.txt and is 4,361 bytes in size. 
FIELD OF THE INVENTION 
The present invention relates generally to DNA hybridiza-
tion techniques for use in creation of functional DNA sur-
faces. Specifically, the present invention relates to the use of 
cinnamate as a cross-linker in DNA-directed nano-particle 
structures. 
BACKGROUND OF THE INVENTION 
Complex self-assembly processes require components to 
associate with particular partners in a preprogrammed fash-
ion. DNA functionalization of nanoconstructs, nanoparticles, 
and micron-scale colloids has proven effective in getting spe-
cific cohesion between pairs of components and in forming 
structures. The hybridization behavior of DNA has been 
extensively studied for decades. Aside from genetic detec-
tion, DNA hybridization has been used to build designable 
DNA nano-structures, DNA-directed nano-particle struc-
tures, and micron particle structures. Such DNA engineering 
techniques can be utilized for DNA computing (processors), 
and in DNA chips, multifunctional colloidal particles as used 
in drug delivery, and complex colloidal self-assembly. 
The highly specific, then noreversible paired interactions 
that are formed by complementary DNA strands play an 
important role in biology and have recently been exploited as 
key building blocks particularly in nanotechnology as a strat-
egy to selectively bind and create a host of potentially impor-
tant structures and functional systems including crystals, 
motors/robots, computers, replicators, and machines. It is 
highly desirable to crosslink some or all of these bonds per-
manently for nanotechnological applications, as well as for 
biological assays. Several crosslinking methods have been 
investigated previously. Psoralen, a highly exploited 
crosslinking agent, intercalates between hybridized thymi- 
2 
dine-adenosine dinucleosides in a DNA sequence and reacts 
with the thymines upon exposure to UV light, forming cova-
lent links. However, the crosslinking efficiency for psoralen 
in solution is low (effective cross section 5x10 -6 nm2) or 
5 requires a very specific attachment of the psoralen group at 
the start of a DNA "sticky end" next to a T-A sequence. 
Cinnamate is one of the most extensively studied photo-
crosslinkers used in DNA hybridization. Cinnamate-func-
tionalized polymers are known to undergo crosslinking via 
10 photocycloaddition reactions upon exposure to UV radiation. 
Generally, cinnamate attaches to DNA strands using a phos-
phoramidite group, wherein a cinnamate on one strand is 
photo -cros slinked with an adjunct adenine base on another 
strand. However, the crosslinking efficiency is low, requiring 
15 approximately 30 minutes of incubation time for hybridiza-
tion given an intensity of about 5.7 mW/cm2 . 
There remains, therefore, a need for efficient, specific, and 
permanent DNA crosslinking methods for use in biological 
assays, drug delivery, processors, and other nanoparticle 
20 structures. 
SUMMARY OF THE INVENTION 
The present invention is based on the discovery that cin- 
25 namate groups may be substituted for a base pair and 
covalently bonded on complementary hybridized nucleic 
acid strands, developed to address the problems with existing 
techniques outlined above. 
Additional features, advantages, and embodiments of the 
30 present disclosure may be set forth from consideration of the 
following detailed description, drawings, and claims. More-
over, it is to be understood that boththe foregoing summary of 
the present disclosure and the following detailed description 
are exemplary and intended to provide further explanation 
35 without further limiting the scope of the present disclosure 
claimed. 
In one aspect, the present invention provides a composi-
tion, such as an aggregate or a liquid dispersion, comprising a 
first substrate having at a first surface nucleic acid strand 
40 comprising a first cinnamate functional group or derivative 
thereof and forming a first sticky end, a second substrate 
having a second surface nucleic acid strand comprising a 
second cinnamate functional group or derivative thereof and 
forming a second sticky end, the first sticky end and the 
45 second stick end substantially complementary and hybridiz-
able with each other; wherein the first colloidal particle and 
the second colloidal particle are covalently bonded via the 
first cinnamate group and the second cinnamate functional 
group. 
50 	 In some embodiments, the covalent bonding is the result of 
a hybridization step and a subsequent UV exposure step. Such 
a hybridization step may take place as a result of a heating 
step. In further embodiments, the 5' end of the nucleic acid 
strand may be connected to a tetraethylene glycol spacer 
55 terminated by a biotin group. The sticky end may, in some 
embodiments, have a sequence of 5'-TACG-linker-CGTA-3', 
and the linker may be cinnamate or a derivative thereof. The 
UV exposure step may, in still further embodiments, take 
place for less than 30 minutes, less than 20 minutes, less than 
60 15 minutes, less than 10 minutes, less than 5 minutes, less 
than 15 seconds, or less than 10 seconds at an intensity of 3.6 
mW/cm2 . 
In another aspect, a biochip is provided a support substrate 
a functional nucleic acid surface strand bound to the support 
65 substrate; the surface strand hybridized from its 5' end with a 
complementary nucleic acid strand, the 3' end of each surface 
nucleic acid strand having a sticky end comprising cinnamate 
US 9,267,171 B2 
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or a derivative thereof; and at least one linker strand compris-
ing a surface strand portion complementary to the sticky end 
of the surface strand and comprising cinnamate covalently 
bound with the cinnamate of the surface strand the linker and 
a target portion comprising a sticky end having a sequence 
substantially complementary to a target material. 
In some embodiments, the substrate may be substrate 
selected from the group consisting of a membrane, glass, 
plastic, or a bead. In further embodiments, the surface may be 
multifunctional. In still further embodiments, the surface 
strand may be bound to the surface via a thiol, via biotin-
streptavidin chemistry, or via amine chemistry such as ami-
dine-NHS interaction. The covalent bonding may, in some 
embodiments, be achieved via the steps of (1) annealing the 
linker strand to the surface strand by decreasing the tempera-
ture from about 50° C. to about 25° C., and (2) permanently 
cross-linking the strands by application of UV, optionally 
further comprising the steps of reheating the biochip to about 
50° C. and washing the biochip with eluent to remove the 
hybridized linker strand. 
Another aspect of the present invention provides a method 
of photolithography comprising exposing a functionalized 
surface to conditions such that a linker strand hybridizes to a 
surface nucleic acid strand, exposing desired portions of the 
functionalized surface to UV light for less than 30 minutes, 
removing excess linker strand, and treating the functionalized 
surface with a target analyte, particle, or sequence; wherein 
each surface nucleic acid strand is hybridized from its 5' end 
with a complementary nucleic acid strand having fewer 
unpaired nucleotides than the surface nucleic acid strand such 
that one base acts as a hinge and at least two unpaired bases 
are left as a sticky end, the sticky end further comprising a 
cinnamate linker; and wherein the linker strand comprises 
two parts, a portion complementary to the sticky end of the 
surface nucleic acid and comprising a cinnamate, and a sec-
ond portion complementary to a sticky end of an the target 
analyte, particle, or sequence. 
In some embodiments, the hybridization conditions com-
prise a decrease in temperature from about 50° C. to about 25° 
C. In further embodiments, the step of removing excess linker 
strand comprises increasing the temperature of the surface to 
about 50° C. and/or washing the surface with an eluent solu-
tion. The target may, in some embodiments, be a probe, 
nucleic acid-tagged particle, or a biologically active agent. 
Furthermore, the desired portions for patterning may be 
between about 1 µm and about 500 µm, between about 1 and 
about 200 µm, or between about 1 and about 50 µm. 
BRIEF DESCRIPTION OF THE DRAWINGS 
The foregoing and other objects, aspects, features, and 
advantages of the disclosure will become more apparent and 
better understood by referring to the following description 
taken in conjunction with the accompanying drawings, in 
which: 
FIGS. 1A-B are a schematic representation of cinnamate-
containing nucleoside and cycloaddition products. FIG. 1(A) 
demonstrates the cycloaddition between two cinnamate 
groups, with only E isomers shown, and their potential con-
figurations, and FIG. 1(B) shows the cinnamate-containing 
nucleoside for incorporation into DNA; 
FIG. 2(A) shows the results of a 10% denaturing electro-
phoretic gel on samples with and without crosslinking; FIG. 
2(B) is a set of micrographs of the aggregation of DNA-
coated 1 micron colloidal particles; and FIG. 2(C) is a histo- 
4 
gram showing the fraction of unaggregated particles as a 
function of UV exposure time for particles with and without 
crosslinkers; 
FIG. 3(A) is a schematic showing DNA constructs and the 
5 position of cinnamate crosslinkers. FIG. 3(B) is a schematic 
showing a procedure to make a multi-functional DNA sur-
face, with steps (1)-(2) showing hybridization of a linker 
strand to a surface strand from 55 to 25° C. in half an hour; 
step (3) showing a permanent UV cross-link between the 
10 surface and linker strands in areas with a black dot; step (4) 
showing a de-hybridization of unlinked strands at 55' C.; step 
(5) showing reversibly binding colloids to the patterned 
regions, and step (6) showing the use of fluorescently labeled 
complementary DNA strands; 
15 	 FIGS. 4A-B illustrate DNA photolithographic patterns: 
Right: exposed patterns with different feature sizes (-14 µm 
in a and 4 and 1.5 µm in b); left:colloid patterns (inverted so 
unstuck particles have escaped); middle: green fluorescently 
labelled conjugate images. FIG. 4C is illustrates multi-func- 
20 tionalizedpatterns of `nature materials' (abbreviated as 'n m') 
in New Times Roman font. Left: green fluorescently labelled 
DNA hybridizes to the LS patterned in the region `materials,' 
and red streptavidin binds to the LS2-patterned biotin in the 
region `nature'. Right: similar patterning of larger `n' and `m' 
25 letters. Separate confocal filtering channels are shown as 
smaller figures. All scale bars are 20 µm; 
FIG. 5(A) is a set of fluorescent images (first row) and 
colloid images (second row) and the exposed pattern, and a 
graph of the intensity profile between the dashed lines along 
30 the x axis FIG. 5(B) is a set of photographs superimposing the 
colloidal images and fluorescent images with the exposed 
pattern (scale bar at 20 µm); 
FIG. 6 is a schematic showing a common route for the 
synthesis of cinnamate; 
35 	 FIG. 7A is an audioradiogram of a 10% denaturing gel run 
wherein one strand of duplex was labeled radioactively by 
32P. Lane 1 is the control, with lanes 2-12 showing progres-
sive exposure to 360 nm UV light for 0,1, 3, 5,10, 40, 70, 120, 
180, 240, and 1320 minutes respectively. 7B is a histogram 
40 showing the crosslinking yield; 
FIG. 8 is a series of photographs showing reversible aggre-
gation-dissociation behavior or DNA coated colloids after 
UV exposure for 2 s, 5 s, 10 s, or 15 s), the behavior of 
particles after heating. Both 10 s and 15 s achieve –100% 
45 particle cross-linking efficiency; and 
FIG. 9 is a set of photographs showing an approximately 1 
mm circularregion of UV exposure (definedby the projection 
of circular aperture on the microscope), after UV exposure 
and cross-link at 20 degrees Celsius. Inside the exposure 
50 region, as shown at left, crosslinking leads to irreversible 
clusters. Outside the exposure region, as shown at right, tem-
perature reversible behavior remains. The phenomenon is 
most evident at the boundary, shown in the middle photo-
graph. 
55 
DETAILED DESCRIPTION OF THE PREFERRED 
EMBODIMENTS 
In the following detailed description, reference is made to 
60 the accompanying drawings, which form a part hereof. In the 
drawings, similar symbols typically identify similar compo- 
nents, unless context dictates otherwise. The illustrative 
embodiments described in the detailed description, drawings, 
and claims are not meant to be limiting. Other embodiments 
65 may be utilized, and other changes may be made, without 
departing from the spirit or scope of the subject matter pre- 
sented here. It will be readily understood that the aspects of 
US 9,267,171 B2 
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the present disclosure, as generally described herein, and 
illustrated in the figures, can be arranged, substituted, com-
bined, and designed in a wide variety of different configura-
tions, all of which are explicitly contemplated and made part 
of this disclosure. 5 
The present invention is based upon the discovery that 
cinnamate groups may be substituted for a base pair and 
covalently bonded on complementary hybridized nucleic 
acid strands, resulting in an efficient, specific, and permanent 
bond that may be used in many biological and nanotechno- io 
logical applications. 
Oligonucleotides 
As used herein, the term "oligonucleotide" includes two or 
more nucleomonomers covalently coupled to each other by 
linkages or substitute linkages. An oligonucleotide may com- 15 
prise, for example, between a few (e.g., 7, 10, 12, 15) or a few 
hundred (e.g., 100, 200, 300, or 400) nucleomonomers. For 
example, an oligonucleotide of the invention preferably com-
prises between about 10 and about 50 nucleomonomers, 
between about 15 and about 40, or between about 20 and 20 
about 30 nucleomonomers. In one embodiment, an oligo-
nucleotide comprises about 25 nucleomonomers. In another 
embodiment, an oligonucleotide comprises greater than 
about 25 nucleomonomers. Oligonucleotides may comprise, 
for example, oligonucleotides, oligonucleotides, polydeox- 25 
yribonucleotides (containing 2'-deoxy-D-ribose) or modified 
forms thereof, e.g., DNA, polyribonucleotides (containing 
D-ribose or modified forms or analogs thereof), RNA, or any 
other type of polynucleotide which is an N-glycoside or 
C-glycoside of a purine or pyrimidine base, or modified 30 
purine or pyrimidine base. The term oligonucleotide includes 
compositions in which adjacent nucleomonomers are linked 
via phosphorothioate, amide or other linkages (e.g., Neilsen, 
P. E., et al. 1991. Science. 254:1497). Generally, the term 
"linkage" refers to any physical connection, preferably cova- 35 
lent coupling, between two or more nucleic acid components, 
e.g., catalyzed by an enzyme such as a ligase. The term 
"oligonucleotide" includes any structure that serves as a scaf-
fold or support for the bases of the oligonucleotide, where the 
scaffold permits binding to the target nucleic acid molecule in 40 
a sequence-dependent manner. 
As used herein, an "sticky end" is a relatively short single-
stranded nucleotide sequence on the 5'- or 3'-hydroxyl end of 
a double-stranded oligonucleotide molecule used to control 
the arrangement of linear segments of DNA (also referred to 45 
as an "extension," "protruding end," or "overhang"). 
As used herein, the term "base" includes the known purine 
and pyrimidine heterocyclic bases, deazapurines, and analogs 
(including heterocycl substituted analogs, e.g., aminoethy-
oxy phenoxazine), derivatives (e.g., 1-alkenyl-, 1-alkynyl-, 50 
heteroaromatic-, and 1-alkynyl derivatives) and tautomers 
thereof. Examples of purines include adenine, guanine, 
inosine, diaminopurine, and xanthine and analogs (e.g., 
8-oxo-N6-methyladenine or 7-diazaxanthine) and derivatives 
thereof. Pyrimidines include, for example, thymine, uracil, 55 
and cytosine, and their analogs (e.g., 5 -methylcyto sine, 5-me-
thyluracil, 5-(1-propynyl)uracil, 5-(1 -propynyl)cyto sine and 
4,4 -ethanocyto sine). Other examples of suitable bases 
include non-purinyl and non-pyrimidinyl bases such as 
2-aminopyridine and triazines 60 
As used herein, the term "nucleoside" includes bases 
which are covalently attached to a sugar moiety, preferably 
ribose or deoxyribose. Examples of preferred nucleosides 
include ribonucleosides and deoxyribonucleo sides. Nucleo-
sides also include bases linked to amino acids or amino acid 65 
analogs which may comprise free carboxyl groups, free 
amino groups, or protecting groups. Suitable protecting  
6 
groups are well known in the art (see P. G. M. Wins and T. W. 
Greene, "Protective Groups in Organic Synthesis", 2" d Ed., 
Wiley-Interscience, New York, 1999). 
Oligonucleotides of the invention can be synthesized by 
any methods known in the art, e.g., using enzymatic synthesis 
and chemical synthesis. The oligonucleotides can be synthe-
sized in vitro (e.g., using enzymatic synthesis and chemical 
synthesis) or in vivo (using recombinant DNA technology 
well known in the art. 
In a preferred embodiment, chemical synthesis is used. 
Chemical synthesis of linear oligonucleotides is well known 
in the art and can be achieved by solution or solid phase 
techniques. Preferably, synthesis is by solid phase methods. 
Oligonucleotides can be made by any of several different 
synthetic procedures including the phosphoramidite, phos-
phite triester, H-phosphonate, and phosphotriester methods, 
typically by automated synthesis methods. 
Oligonucleotide synthesis protocols are well known in the 
art and can be found, e.g., in U.S. Pat. No. 5,830,653; WO 
98/13526; Stec et al. 1984. J. Am. Chem. Soc. 106:6077; Stec 
et al. 1985. J. Org. Chem. 50:3908; Stec et al. J. Chromatog. 
1985.326:263; LaPlanche et al. 1986. Nuc. Acid. Res. 1986. 
14:9081; Fasman G. D., 1989. Practical Handbook of Bio-
chemistry and Molecular Biology. 1989. CRC Press, Boca 
Raton, Fla.; Lamone. 1993. Biochem. Soc. Trans. 21:1; U.S. 
Pat. No. 5,013,830; U.S. Pat. No. 5,214,135; U.S. Pat. No. 
5,525,719; Kawasaki et al. 1993. J. Med. Chem. 36:831; WO 
92/03568; U.S. Pat. No. 5,276,019; U.S. Pat. No. 5,264,423. 
The synthesis method selected can depend on the length of 
the desired oligonucleotide and such choice is within the skill 
of the ordinary artisan. For example, the phosphoramidite and 
phosphite triester methods produce oligonucleotides having 
175 or more nucleotides while the H-phosphonate method 
works well for oligonucleotides of less than 100 nucleotides. 
If modified bases are incorporated into the oligonucleotide, 
and particularly if modified pho sphodiester linkages are used, 
then the synthetic procedures are altered as needed according 
to known procedures. In this regard, Uhlmann et al. (1990, 
Chemical Reviews 90:543-584) provide references and out-
line procedures for making oligonucleotides with modified 
bases and modified phosphodiester linkages. Other exem-
plary methods for making oligonucleotides are taught in Son-
veaux. 1994. "Protecting Groups in Oligonucleotide Synthe-
sis"; Agrawal. Methods in Molecular Biology 26:1. 
Exemplary synthesis methods are also taught in "Oligonucle-
otide Synthesis A Practical Approach" (Gait, M. J. IRL 
Press at Oxford University Press. 1984). Moreover, linear 
oligonucleotides of defined sequence can be purchased com-
mercially. 
The oligonucleotides may be purified by polyacrylamide 
gel electrophoresis, or by any of a number of chromato-
graphic methods, including gel chromatography and high 
pressure liquid chromatography. To confirm a nucleotide 
sequence, oligonucleotides may be subjected to DNA 
sequencing by any of the known procedures, including 
Maxam and Gilbert sequencing, Sanger sequencing, capillary 
electrophoresis sequencing the wandering spot sequencing 
procedure or by using selective chemical degradation of oli-
gonucleotides bound to Hybond paper. Sequences of short 
oligonucleotides can also be analyzed by laser desorption 
mass spectroscopy or by fast atom bombardment (McNeal, et 
al., 1982, J. Am. Chem. Soc. 104:976; Viari, et al., 1987, 
Biomed. Environ. Mass Spectrom. 14:83; Grotjahn et al., 
1982, Nuc. Acid Res. 10:4671). Sequencing methods are also 
available for RNA oligonucleotides. 
The quality of oligonucleotides synthesized can be verified 
by testing the oligonucleotide by capillary electrophoresis 
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and denaturing strong anion HPLC (SAX-HPLC) using, e.g., 	 ytrityl)-4-hydroxy cinnamate-l'-p-deoxyriboside ("Com- 
the method of Bergot and Egan. 1992. J. Chrom. 599:35. 	 pound 3") as a white solid. To a solution of Compound 3 
Other exemplary synthesis techniques are well known in 	 (690.0 mg, 1.16 mmol), and N N-diisopropylethylamine 
the art (see, e.g., Sambrook et al., Molecular Cloning: a Labo- 	 (0.41 ml, 2.32 mmol) in pyridine (anh.) is added 2-cyanoethyl 
ratory Manual, Second Edition (1989); DNA Cloning, Vol-  5 N N-diisopropyl chlorophosphoramidite (0.31 mL, 1.39 
umes I and II (DN Glover Ed. 1985); Oligonucleotide Syn- 	 mmol) and stirred at room temperature for 30 minutes. The 
thesis (M J Gait Ed, 1984; Nucleic Acid Hybridisation (B D 	 solution is concentrated under high vacuum and the precipi- 
Flames and S J Higgins eds. 1984); A Practical Guide to 	 tate is dissolved in ethyl acetate. The organic solution is 
Molecular Cloning (1984); or the series, Methods in Enzy- 	 washed with water, NaHCO3, brine, and dried over Na2SO4. 
mology (Academic Press, Inc.)). 	 io The crude material purified by chromatography (1:1 ethyl 
Cinnamate 	 acetate:hexanes; 1% triethylamine) to give 761.7 mg (82%) 
As used herein, a "crosslinker" is a chemical compound 	 of 5'-O-(4,4'-dimethoxytrityl)-4-hydroxy cinnamate-l'-p- 
having two or more polymerizable groups. In general, any 	 deoxyribo side-3'-O-(cyanoethoxy-N,N-dii sopropylamino) 
crosslinking compound may be used, so long as the polymer- 	 phosphoramidite ("Compound 4"). 
izable groups on the crosslinker are capable of forming a 15 Biochip/Array 
crosslinked co-polymer between the enzymes and the at least 	 Nucleic acids used in the present invention can be immo- 
one monomer unit under the conditions used to form the 	 bilized to or applied to an array or "biochip". As used herein, 
nanocomplex. Examples of crosslinkers include compounds 	 a "biochip" refers to a solid substrate having a generally 
having two vinyl, acryl, alkylacryl, or methacryl groups. 	 planar surface to which a capture reagent (adsorbent) is 
Examples of specific crosslinkers having two acryl groups 20 attached. Frequently, the surface of the biochip comprises a 
include N,N'-methylenebisacrylamide and glycerol 	 plurality of addressable locations, each of which location has 
dimethacrylate. In preferred embodiments of the present 	 the capture reagent bound there. Biochips can be adapted to 
invention, the crosslinker is cinnamate or a derivative thereof. 	 engage a probe interface and, therefore, function as probes. In 
The term "binding" or "binds" as used herein are meant to 	 practicing the methods of the invention, any known array 
include interactions between molecules that may be detected 25 and/or method of making and using arrays can be incorpo- 
using, for example, a hybridization assay. The terms are also 	 rated in whole or in part, or variations thereof, as disclosed, 
meant to include "binding" interactions between molecules. 	 for example, in U.S. Pat. Nos. 6,277,628; 6,277,489; 6,261, 
Interactions may be, for example, protein-protein, antibody- 	 776; 6,258,606; 6,054,270; 6,048,695; 6,045,996; 6,022,963; 
protein, protein-nucleic acid, protein-small molecule or small 
	
6,013,440; 5,965,452; 5,959,098; 5,856,174; 5,830,645; 
molecule-nucleic acid in nature. This binding can result in the 3o 5,770,456; 5,632,957; 5,556,752; 5,143,854; 5,807,522; 
formation of a "complex" comprising the interacting mol- 	 5,800,992; 5,744,305; 5,700,637; 5,556,752; 5,434,049; see 
ecules. A "complex" refers to the binding of two or more 	 also, e.g., WO 99/51773; WO 99/09217; WO 97/46313; WO 
molecules held together by covalent or non-covalent bonds, 	 96/17958; see also, e.g., Johnston, Curr. Biol. 8:R171-R174, 
interactions or forces. 	 1998; Schummer, Biotechniques 23:1087-1092, 1997; Kern, 
Cinnamate may be synthesized by any known method, 35 Biotechniques 23:120-124, 1997; Solinas-Toldo, Genes, 
such as, for example, but not limited to, the method shown in 	 Chromosomes & Cancer 20:399-407, 1997; Bowtell, Nature 
FIG. 6, starting with a solution of methyl 4-hydroxy cin- 	 Genetics Supp. 21:25-32, 1999. See also published U.S. 
namate (1.58 g, 8.85 mmoles), 2,5-di-O-(p-toluyl)-2-deoxy- 	 Patent Applications Nos. 20010018642; 20010019827; 
D-ribofuranosyl chloride (2.0 g, 5.9 mmoles), and cesium 	 20010016322;20010014449;20010014448;20010012537; 
carbonate (3.27 g, 10.0 mmol) in tetrahydrofuran. In FIG. 6, 4o 20010008765. 
the solution is stirred at room temperature overnight. The 	 As used herein, a "substrate" refers to the material to which 
solution is filtered and the filtrate concentrated under high 	 the surface nucleic acides of the presently claimed composi- 
vacuum. The crude solid is purified by column chromatogra- 	 tions and methods are attached. The substrate may be any 
phy (98.5:1.5 DCM:MeOH) to give 1.97 g (63%) of 4-hy- 	 material, such as a membrane, glass, plastic, bead, nanopar- 
droxy cinnamate-l'-p-deoxyriboside-3',5'-di-(p-toluoyl)es-  45 ticle, or photonic/plasmodic structure, and may be solid, 
ter ("Compound I") as a white solid. Compound 1 is stirred in 	 semi-solid, fibrous, capillary or porous. 
1.93 ml (10.7 mmol) of sodium methoxide (30% w/v in 	 Arrays are generically a plurality of "target elements" or 
McOH) at room temperature for two days. The mixture is 	 "spots," each target element containing a defined amount of 
neutralized with a 10% acetic acid solution followed by 	 one or more biologically molecules, e.g., polypeptides, 
extraction three times with DCM. The combined organic 5o nucleic acid molecules, or probes, immobilized at discrete 
layers are washed with water and brine, and dried over 	 locations on a substrate surface. In preferred embodiments, 
Na2SO4 . The solution is concentrated under high vacuum and 	 the plurality of spots comprises nucleic acid segments, immo- 
the crude solid is purified by column chromatography (gra- 	 bilized at preferably at least about 50, at least about 100, at 
dient 0-5% McOH; DCM) to give 1.05 g (99.5%) of 4-hy- 	 least about 300, or at least about 500 discrete locations on the 
droxy cinnamate-l'-p-deoxyriboside ("Compound 2") as a 55 surface. The plurality may comprise multiple repeats of the 
white solid. To a solution of Compound 2 (610.0 mg, 2.07 	 same nucleic acid segments to produce, e.g., duplicate spots, 
mmoles) and N,N-diisopropylethylamine (0.54 ml, 3.11 	 triplicate spots, quadruplicate spots, quintuplicate spots, etc. 
mmoles) inpyridine (anh.) is added 4,4'-dimethoxytriphenyl- 	 As used herein, the term "target gene" includes polynucle- 
methyl chloride (351.2 mg 1.04 mmol) and stirred at room 	 otides comprising a region that encodes a polypeptide or 
temperature. Ater an hour, additional 4,4'-dimethoxytriph-  60 polynucleotide region that regulates replication, transcrip- 
enylmethyl chloride (351.2 mg, 1.04 mmol) is added to the 	 tion, translation, or other process important in expression of 
mixture and stirred for one hour. The solution is concentrated 	 the target protein or a polynucleotide comprising a region that 
under high vacuum yielding a pasty yellow precipitate which 	 encodes the target polypeptide and a region that regulates 
is dissolved in ethyl acetate and washed with water, NaHCO 31 	 expression of the target polypeptide. The "target gene" to 
brine, and dried over Na 2 SO4. The crude material is purified 65 which an RNA molecule of the invention is directed may be 
by chromatography (1:1 ethyl acetate:hexanes; 1% tri- 	 associated with a pathological condition. For example, the 
ethyamine) to give 990.0 mg (80%) of 5'-O-(4,4'-dimethox- 	 gene may be a pathogen-associated gene, e.g., a viral gene, a 
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tumor-associated gene, or an autoimmune disease-associated 
gene. The target gene may also be a heterologous gene 
expressed in a recombinant cell or a genetically altered organ-
ism. By determining ormodulating (e.g., inhibiting) the func-
tion of such a gene, valuable information and therapeutic 
benefits in medicine, veterinary medicine, and biology may 
be obtained. 
A "biologically active agent" or an active agent of this 
invention intends one or more of an isolated or recombinant 
polypeptide, an isolated or recombinant polynucleotide, a 
vector, an isolated host cell, or an antibody, as well as com-
positions comprising one or more of same. 
As used herein "analyte" refers to any component of a 
sample that is desired to be detected. The term can refer to a 
single component or a plurality of components in the sample. 
In an embodiment of the present invention, the immobi-
lized nucleic acid molecules are contacted with a linker strand 
comprising cinnamate for specific binding, e.g., hybridiza-
tion. As used herein, "hybridization" involves free, single-
stranded stretches of nucleic acids. Accordingly, a nucleic-
acid network may be regulated by the availability of these free 
strands. "Hybridization" refers to a reaction in which one or 
more polynucleotides react to form a complex that is stabi-
lized via hydrogen bonding between the bases of the nucle-
otide residues. The hydrogen bonding may occur by Watson-
Crick base pairing, Hoogstein binding, or in any other 
sequence-specific manner. The complex may comprise two 
strands forming a duplex structure, three or more strands 
forming a multi-stranded complex, a single self-hybridizing 
strand, or any combination of these. A hybridization reaction 
may constitute a step in a more extensive process, such as the 
initiation of a PCR reaction, or the enzymatic cleavage of a 
polynucleotide by a ribozyme. 
Examples of "stringent" hybridization conditions include, 
but are not limited to: incubation temperatures of about 25' C. 
to about 37° C.; hybridization buffer concentrations of about 
6x standard sodium citrate (SSC) to about I0xSSC; forma-
mide concentrations of about 0% to about 25%; and wash 
solutions of about 6xSSC. Examples of moderate hybridiza-
tion conditions include: incubation temperatures of about 40° 
C. to about 50° C.; buffer concentrations of about 9xSSC to 
about 2xSSC; formamide concentrations of about 30% to 
about 50%; and wash solutions of about 5xSSC to about 
2xSSC. Examples of high stringency conditions include: 
incubation temperatures of about 55° C. to about 68° C.; 
buffer concentrations of about 1xSSC to about O.1xSSC; 
formamide concentrations of about 55% to about 75%; and 
wash solutions of about 1 xSSC, 0.1 xSSC, or deionized water. 
In general, hybridization incubation times are from 5 minutes 
to 24 hours, with 1, 2, or more washing steps, and wash 
incubation times are about 1, 2, or 15 minutes. SSC is 0.15 M 
NaCl and 15 mM citrate buffer. It is understood that equiva-
lents of SSC using other buffer systems can be employed. 
Once UV light is applied to any portion of the array desired, 
covalently binding the linker strand to the nucleic acid seg-
ment immobilized on the biochip, the linker strand may fur-
ther hybridize to a target element. Target elements may con-
tain, but are not limited to, whole or partial DNA sequences, 
reference sequences, such as positive and negative controls, 
and the like. The target elements of the arrays may be 
arranged on the substrate surface at different sizes and differ-
ent densities. Different target elements of the arrays can have 
the same molecular species, but, at different amounts, densi-
ties, sizes, labeled or unlabeled, and the like. The target ele-
ment sizes and densities will depend upon a number of fac-
tors, such as the nature of the label (the immobilized molecule 
can also be labeled), the substrate support (it is solid, semi-
solid, fibrous, capillary or porous), and the like. 
Each target element may comprise substantially the same 
nucleic acid sequences, or, a mixture of nucleic acids of 
5 different lengths and/or sequences. Thus, for example, a tar-
get element may contain more than one copy of a cloned piece 
of DNA, and each copy may be broken into fragments of 
different lengths, as described herein. The length and com-
plexity of the nucleic acid fixed onto the biochip surface is not 
io critical to the invention. The biochip can comprise nucleic 
acids immobilized on any substrate, e.g., a solid surface (e.g., 
nitrocellulose, glass, quartz, fused silica, plastics and the 
like). See, e.g., U.S. Pat. No. 6,063,338 describing multi-well 
platforms containing cycloolefin polymers if fluorescence is 
15 to be measured. Arrays used in the methods of the invention 
can comprise housing containing components for controlling 
humidity and temperature during the hybridization and wash 
reactions. 
Many methods for immobilizing nucleic acids on a variety 
20 of solid surfaces are known in the art. For instance, the solid 
surface may be a membrane, glass, plastic, or a bead. The 
desired component may be covalently bound or nonco-
valently attached through nonspecific binding. The immobi-
lization of nucleic acids on solid surfaces is discussed more 
25 fully below. 
A wide variety of organic and inorganic polymers, as well 
as other materials, both natural and synthetic, may be 
employed as the material for the solid surface. Illustrative 
solid surfaces include nitrocellulose, nylon, glass, diazotized 
30 membranes (paper or nylon), silicones, polyformaldehyde, 
cellulose, and cellulose acetate. In addition, plastics such as 
polyethylene, polypropylene, polystyrene, and the like can be 
used. Other materials which may be employed include paper, 
ceramics, metals, metalloids, semiconductive materials, cer- 
35 mets or the like. In addition substances that form gels can be 
used. Such materials include proteins (e.g., gelatins), 
lipopolysaccharides, silicates, agarose and polyacrylamides. 
Where the solid surface is porous, various pore sizes may be 
employed depending upon the nature of the system. 
40 In preparing the surface of a solid support for array print-
ing, a plurality of different materials may be employed, par-
ticularly as laminates, to obtain various properties. For 
example, proteins (e.g., bovine serum albumin) or mixtures of 
macromolecules (e.g., Denhardt's solution) can be employed 
45 to avoid non-specific binding, simplify covalent conjugation, 
enhance signal detection or the like. 
If covalent bonding between a compound and the surface is 
desired, the surface may be polyfunctional or be capable of 
being polyfunctionalized. Functional groups which may be 
50 present on the surface and used for linking can include car-
boxylic acids, aldehydes, amino groups, cyano groups, eth-
ylenic groups, hydroxyl groups, mercapto groups and the 
like. The manner of linking a wide variety of compounds to 
various surfaces is well known and is amply illustrated in the 
55 literature. For example, methods for immobilizing nucleic 
acids by introduction of various functional groups to the 
molecules is known (see, e.g., Bischoff et al., Anal. Biochem. 
164:336-344, 1987); Kremsky et al., Nucl. Acids Res. 
15:2891-2910, 1987). Modified nucleotides can be placed on 
60 the target using PCR primers containing the modified nucle-
otide, or by enzymatic end labeling with modified nucle-
otides. 
Alternative surfaces include derivatized surfaces such as 
chemically coated glass slides. On example, is the 
65 CodeLinkTM Activated Slide from Amersham Biosciences. 
These slides are coated with a novel 3-D surface chemistry 
comprised of a long-chain, hydrophilic polymer containing 
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amine-reactive groups, to react with and covalently immobi-
lize amine-modified DNA for microarrays. This polymer is 
covalently crosslinked to itself and to the surface of the slide 
and is designed to orient the immobilized DNA away from the 
surface of the slide to improve hybridization. Another such 
3D slide is UltraGapTM, sold by Dow Corning. 
Use of membrane supports (e.g., nitrocellulose, nylon, 
polypropylene) for the nucleic acid arrays of the invention is 
advantageous because of well developed technology employ-
ing manual and robotic methods of arraying targets at rela-
tively high element densities (e.g., up to 30-40/cm 2). In addi-
tion, such membranes are generally available and protocols 
and equipment for hybridization to membranes is well 
known. Many membrane materials, however, have consider-
able fluorescence emission, where fluorescent labels are used 
to detect hybridization. 
Aside from the demonstrated applications with colloids 
and on substrates, the specific and efficient crosslinking of the 
cinnamate crosslinker may also be used in other applications 
to make assembled structures. For example, DNA directed 
nano-particle assembly, emulsion droplets, and plasmonic 
materials are also contemplated as substrates. 
To optimize a given assay format one of skill can determine 
sensitivity of fluorescence detection for different combina-
tions of membrane type, fluorophore, excitation and emission 
bands, spot size and the like. In addition, low fluorescence 
background membranes have been described (see, e.g., Chu 
et al., Electrophoresis 13:105-114, 1992). 
The sensitivity for detection of spots of various diameters 
on the candidate membranes can be readily determined by, for 
example, spotting a dilution series of fluorescently end 
labeled DNA fragments. These spots are then imaged using 
conventional fluorescence microscopy. The sensitivity, lin-
earity, and dynamic range achievable from the various com-
binations of fluorophore and membranes can thus be deter-
mined. Serial dilutions of pairs of fluorophore in known 
relative proportions can also be analyzed to determine the 
accuracy with which fluorescence ratio measurements reflect 
actual fluorophore ratios over the dynamic range permitted by 
the detectors and membrane fluorescence. 
Arrays on substrates with much lower fluorescence than 
membranes, such as glass, quartz, or small beads, can achieve 
much better sensitivity. For example, elements of various 
sizes, ranging from about 1 mm diameter down to about 1 µm 
can be used with these materials. Small array members con-
taining small amounts of concentrated target DNA are con-
veniently used for high complexity comparative hybridiza-
tions since the total amount of probe available for binding to 
each element will be limited. Thus, it is advantageous to have 
small array members that contain a small amount of concen-
trated target DNA so that the signal that is obtained is highly 
localized and bright. Such small array members are typically 
used in arrays with densities greater than 10 4/cm2 . Relatively 
simple approaches capable of quantitative fluorescent imag-
ing of 1 cm2 areas have been described that permit acquisition 
of data from a large number of members in a single image 
(see, e.g., Wittrup et al., Cytometry 16:206-213, 
Hybridization to nucleic acids attached to beads is accom-
plished by suspending them in the hybridization mix, and 
then depositing them on the glass substrate for analysis after 
washing with eluent. As used herein, "eluant" or "wash solu-
tion" refers to an agent, typically a solution, which is used to 
affect or modify adsorption of an analyte to an adsorbent 
surface and/or remove unbound materials from the surface. 
The elution characteristics of an eluant can depend, for 
example, on pH, ionic strength, hydrophobicity, degree of 
chaotropism, detergent strength and temperature. Alterna- 
12 
tively, paramagnetic particles, such as ferric oxide particles, 
with or without avidin coating, can be used. 
The invention will now be described in greater detail by 
reference to the following non-limiting examples. 
5 
EXAMPLES 
Example 1 
io 	 Specificity and Efficiency of Cinnamate Binding in 
Solution 
For the purposes of the experiments described herein, cin-
namate-functionalized phosphoramidite was obtained in four 
15 high yielding steps. The glycosylation of the cinnamate 
derivative with Hoffer's a-chloro saccharide was achieved 
using cesium carbonate. Sodium methoxide was employed in 
order to remove the p-tol protecting groups, which afforded 
free hydroxyl groups at the 3' and 5' positions of the saccha- 
2o ride. Finally, the 5'-OH was protected with dimethoxytrityl-
chloride followed by conversion of the 3'-OH to a phosphora-
midite. The cinnamate-containing phosphoramidite was 
incorporated into a DNA oligonucleotide using conventional 
procedures. 
25 All UV exposure took place as follows: UV power output 
was measured with a SiC photodiode with peak sensitivity at 
340 mu. The power output 1 cm from the UV lamp was —0.6 
mW/cm2 or —10 photons/sec-nm2. For internal Hg lamp with 
x100 Leica air objective on Leica DMRXA microscope with 
3o Leica Type A filter cube, power output is —60 photons/sec-
nm2 as in the crosslinking experiment on particles. For the 
external Hg lamp with x63 Leica air objective, power output 
is —30 mW/cm 2 or —500 photons/sec-nm 2 as used in Example 
3 below. 
35 To determine whether DNA strands in solution bind only 
selectively with UV exposure, a denaturing gel, FIG. 2(A) is 
used to dehybridize the DNA strands without disruption of 
the covalently bound strands. The gels contained 8.3 M urea 
and were run at 55'C.  The running buffer consisted of 89 mM 
4o Tris, HCl, pH 8.0, 89 mM Boric acid, 2 mM EDTA (TBE). 
The sample buffer consisted of 10 mM NaOH, 1 mM EDTA, 
a trace amount of Xylene Cyanol FF and Bromophenol Blue 
tracking dye. Gels were run on a Hoefer SE 600 electrophore-
sis unit (31 V•cm, constant voltage). When further denatur- 
45 ation was required, a 6% acrylamide gel solution containing 
7.0 M urea and 41% formamide, or a 4% acrylamide gel 
solution containing 6.8 M urea and 47% formamide were 
substituted for a regular denaturing gel. The constructs used 
had complementary cinnamate-modified sticky ends and the 
50 same double strand formed on hybridization, wherein the 
hybridized constructs lacked sticky ends. The constructs are 
referred to as "C" and "D" and the hybridized version as 
"CD," wherein C has the sequence 5'-ATCGCTACCCTTCG-
CACAGTCAATCCAGAGAGCCCTGC- 
55 CTTTCATTACGACCAAGT-crosslinker-TATGA-3' (SEQ 
ID NO: 1), D has the sequence 5'-ATCGCTACCCTTCGCA-
CAGTCAATCCAGAGAGCCCTGC-
CTTTCATTACGATCATA-crosslinker-ACTTGG-3' (SEQ 
ID NO:2), and CS has the sequence 5'-TCGTAATGAAAG- 
60 GCAGGGCTCTCTGGATTGACTGTGC-
GAAGGGTAGCGAT-3' (SEQ ID NO:3). The cinnamate 
nucleoside was inserted at the 7 t'' nucleoside position (in the 
5' to 3' direction), within the 11-base sticky end of the C strand 
as well as the associated 6 t'' base position on the D strand. In 
65 all experiments shown in FIG. 2A, the DNA strands were 
annealed with an equal number of CS strands to hybridize and 
form a construct with a 50 nucleotide pair rigid duplex fol- 
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lowed by an 11 nucleoside sticky end. Lanes 1, 4, and 7 
	
40° C.) than the C and D complementary pair (about 45° C.). 
contain strands C and CS only. Lanes 2, 5, and 8 contain D and 
	
Four sets of experiments were performed using the following 
CS only. Neither temperature nor UV exposure prompt the 	 protocol: 
hybridization of the cinnamate-containing strands C with C 
	
Each sample was annealed by cooling it over a one hour 
or D with D. Lanes 3, 6, and 9 contain both strands C and D, 5 period from 55° C. to room temperature. Each sample was 
and CS. Even though C and D hybridize, without UV expo- 	 then exposed to UV (16 seconds at 60 photons/sec-nm2) at 
sure there is no crosslinking, as seen in lane 3. However, after 	 room temperature and heated to 55° C. for ten minutes. The 
a five-minute exposure to UV light (10 Photons/sec-nm2), 	 first set with P-coated particles dissociated completely upon 
there is substantial crosslinking in lane 6, which is even 	 heating, indicating that UV exposure did not link these DNA 
stronger after 15 minute UV light exposure, as shown in lane 10 functionalized particles. The second set with a mixture of 
9. Thus, two DNA strands are only covalently bonded when 	 particles C and D and the third set with a mixture of particles 
the two cinnamate nucleosides are held in juxtaposition by 	 C+P and D+P showed little dissociation. UV irradiation suc- 
flanking complementary sequences in the sticky ends. 	 cessfully crosslinked the cinnamate modified paired strands 
The efficiency and exposure time dependence of cinnamate 	 and the palindrome did not interfere with the cinnamate 
crosslinking was tested by preparing two 40-mer DNA 15 crosslinking, as shown in FIG. 2B. The set with only particles 
strands with complementary sequences with the cinnamate 	 C+P, however, (FIG. 213, right), almost dissociated com- 
groups incorporated in each strand in place of a complemen- 	 pletely after heating. Though the cinnamate groups on the 
tary pair. The cinnamate groups are held in close proximity, 	 non-complementary strands of two particles were held 
<1 run, by the DNA hybridization of the flanking base pairs. 	 together within a range of about 20 nm, UV exposure was not 
The specific sequences used are 5'-GCTACCCTTCGCA-  20 effective for crosslinking in this case. 
CAGTCAA-cro s Blinker-TCCAGAGAGCCCTGCCTTTC- 	 FIG. 2C compares the fraction of unbound particles for the 
3' (SEQ ID NO: 4) and 5'-GAAAGGCAGGGCTCTCTGGA- 	 equal mixture of complementary cinnamate-modified C and 
crosslinker-TTGACTGTGCGAAGGGTAGC-3' (SEQ ID 	 D particles to the C+P particles. This is a particularly sensitive 
NO:5). The denaturing gel (FIG. 7) was run at 55° C. The first 	 measure since these particles are typically joined by about 
lane is a sample with only A strands. In lanes 2-12, the 25 150 bonds. If any pair is crosslinked, the particles remain 
complementary sequences have been hybridized by anneal- 	 stuck together. This data demonstrates that the selectivity is at 
ing them from 90° C. to 4° C. over a period of 2 hours. At 4° 
	
least 300:1. 
C., they have been exposed to UV for various lengths of time 	 Multifunctional surfaces may also be created using the 
to form the permanent cyclobutyl crosslink between the 	 present methods. For example, as shown in FIG. 3, a three- 
strands via the 2+2 cycloaddition between two cinnamate 30 component structure was designed consisting of a surface 
groups. A denaturing gel indicates no hybridized bonds, thus 	 strand (SS), with a sequence of 5'-RSS-50basesBackbone- 
indicating the formation of larger molecules via a covalent 	 TTGAGAAATGC-cinnamate-CGTAAAGAGTT-3' (SEQ 
link. Hence, the lowerbands withthe same mobility as seen in 	 ID NO: 6); a particle strand (PS), with a sequence of 5'-GGAT- 
the first lane consist of uncrosslinked single strands of SEQ 	 GAAGATG-50basesBackbone-BiotinTEG-3' (SEQ ID 
ID NO:4 or 5. The upper bands with lower mobility corre-  35 NO:7); and a linker strand (LS), having a sequence of 
spond to the higher molecular weight of crosslinked SEQ ID 	 5'-CATCTTCATCCAACTCTTTACG-cinnamate- 
NO :4-SEQ ID NO:5 strands. 	 GCATTTCTCAA-3' (SEQ ID NO: 8). The SS is attached to a 
FIG. 7B shows a plot of the crosslinking yield, the intensity 	 gilded surface by a disulfide group, followed by a 50-bp 
of the upper band in FIG. 7A divided by the sum of the 	 backbone (as shown in FIG. 3A), and an active 22-bp sticky 
intensities of the upper and lower bands versus the UV expo-  40 end with cinnamate. The linker strand has two parts: a cin- 
sure time. The UV source used in this experiment was a UV 	 namate containing sequence complementary to the SS, and a 
lamp whose power output was measured with a SiC photo- 	 functional sequence that is designed to bind specifically to the 
diode with peak sensitivity at 340 run. Power output 1 cm 	 particles or other materials in the system. Finally, the target 
from the lamp was approximately 0.6 mW/cm 2 or approxi- 	 material, here the particles, have a complement to the func- 
mately 10 photons/sec -mn2 . An exposure time of one hour is 45 tional strand. The LS-SS DNA melting temperature without 
sufficient to establish most of the cinnamate crosslinks that 	 UV radiation is approximately 45° C., which ensures highly 
will form, an effective linking cross section of 3x 10-5  nm2. 	 efficient crosslinking at room temperature. 
A Leica DMRXA microscope with Qimaging Retiga 1300 
Example 2 	 camera and Leica external Hg lamp was used to observe 
50 colloidal results. Leica Type  filter cube was used to provide 
Cinnamate-Containing DNA Allows for the 	 365 nm wavelength UV light for the cinnamate crosslinking 
Permanent and Specific Binding of Colloidal 	 Black field masks were purchased from FineLine imaging 
Particles 	 and placed at the aperture conjugated to the sample image. 
In order to investigate the permanent joining of colloidal 55 	 Example 3 
particles with UV light exposure of cinnamate-containing 
DNA, biotin (and 4 bases PEG) were added to sequences C 	 Use of Cinnamate-Containing DNA in Functional 
and D as the terminating group at the 5' end, in order to bind 
	
Photolithoraphy 
to streptavidin coated particles. A similar construct was made 
where the sticky ends were self-complementary palindromic 60 	 In order to confirm the applicability of cinnamate-contain- 
sequences (P) lacking cinnamate. To show that a colloid may 	 ing DNA in functional photolithography methods, a surface 
be functionalized with different DNA strands, five sets of 	 was first functionalized as shown in FIG. 3B. A cover slip (2.5 
particles were created with different coatings using C, D, P, 	 cm by 2.5 cm) was first cleaned using acetone, plasma etched 
C+P, and D+P. The C+P (D+P) particles have half of their 	 by SPI supplies Plasma Prep II, and then evaporated with 5 
surface randomly coated with P strands and half with C (D) 65 nm chromium and 40 nm thickness gold (SIGMA-ALDRICH 
strands. The attached DNA sequence was designed such that 	 99.999%) using a BAL-TEC MCS 010 Multi Control System. 
the P-coated particles had a lower melting temperature (about 	 A thiol attached surface strand (72 bp) was first hybridized 
US 9,267,171 B2 
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with its 49 by complementary strand (SEQ ID NO: 9; 5'-CGT 
AAT GAAAGG CAG GGC TCT CTG GAT TGA CTG TGC 
GAA GGG TAG CGA T-3') from 95° C. to 25° C. to form a 
rigid double stranded backbone and then incubated on the 
gold surface for 12 hours under the following conditions: 25° 
C. normal buffer (10 mM PB, 50 mM NaCl, 1% w/w F127) 
and thiol DNA concentration 40 µM. The small incubation 
chamber was sealed to avoid evaporation. After incubation, 
extra strands were washed out using a 55° C. normal buffer 
repeated three times. This resulted in —3000 µin z  DNA den-
sity as determined by radioactive measurement. The linker 
strands were then hybridized to the surface strands by anneal-
ing them from 55° C. to 25° C. for 30 minutes (steps 1 and 2). 
The samples were then exposed to UV light to permanently 
cross-link the surface and linker strands in the exposed areas 
(step 3). Finally, the sample was heated to 55° C. and washed 
three times to de-hybridize the unlinked strands (step 4). The 
functionalized surface was then capable of reversibly binding 
colloids to the patterned regions. To make spatially dependent 
DNA multifunctionalized surfaces, it is necessary to repeat 
steps 3 and 4 at different places with different linker strands. 
In order to provide the in situ temperature control described 
above, 1000Q ITO glass was placed on a 3 mm thick copper 
plate, two ends of which were connected to peltiers (2.5 cm by 
2.5 cm), then to a thermal sink with constant temperature. 
With LakeShore DRC 93C Temperature Controller and Lake-
Shore PT-111 temperature sensor, the temperature is control-
lable with <0.5° C. relative error. 
The colloids used were created as follows: 1 µm streptavi-
din covered polystyrene particles were purchased from Invit-
rogen (Dynabeads MyOne Streptavidin CI). Biotinylated 
particle strands with a double stranded backbone were incu-
bated with particles for one hour under the following condi-
tions: 25° C., light shaking, normal buffer, particle volume 
fraction 0.05%, and biotinylated strand concentration of 0.5 
µM. Particles were washed by centrifuging and re-suspension 
three times to wash out extra strands. This resulted —6400 
µrn 2 DNA density as determined by radioactive measure-
ment. 
FIG. 4 shows results for the photolithography using the 
above procedure and a NYU mask. A Leica DMRXA micro-
scope with Qimaging Retiga 1300 camera and Leica external 
Hg lamp was used to observe colloidal results. A Leica 
DM6000 CS confocal microscope was used to take all fluo-
rescent images. An argon laser was used for excitation. 
Streptavidin with Alexa Fluror 488 (Invitrogen) was used to 
dye the biotinylated complementary DNA particle strand, 
which was conjugated to the DNA sticky end in the lithogra-
phy pattern. A high salt concentration buffer (500 nM NaCI) 
was used to stabilize the interaction. The particles had a 
gravitational height, kBT/mg —1 micron, and hence sediment. 
Therefore, samples were turned upside down after particle 
binding to show clearly which particles were attached. FIG. 
4A depicts an image of the exposedY along with a decoration 
by 1 micron PS coated polystyrene spheres as well as by PS 
attached to fluorescein labeled streptavidin. Both fluorescent 
and colloid pictures show a minimum feature size of —2 µm 
(FIGS. 4B and Q. The binding between the linker strand and 
either the colloids or the labeled DNA strands is thermor-
eversible. Upon heating, the colloids sediment away from the 
letters and the PS DNA strands diffuse away. Cooling leads to 
reassociation. It was also confirmed that the effective cross 
section of cinnamate by colloid-surface melting temperatures 
is 3x 10-5  mU. 
To make a spatially dependent multi-functionalized sur-
face and demonstrate the versatility of implementations of the 
described methods, the photolithography as described above 
16 
(steps 1 to 6), and then repeated steps 3 and 4 on a different 
region of the gold surface using modified linker strands (steps 
7 and 8). The new linker strand 2 (LS2) contains a functional 
molecule (biotin in this case) at its 5' end, unlike the single- 
5 stranded sticky-end of LS. The newly functionalized region 
of the gold surface with LS2 strands was visualized by the 
conjugation of red fluorescent streptavidin. The sticky LS in 
the first exposure region remained functional as tested by the 
addition of fluorescently labelled PS strands (step 9). 
10 FIG. 4c shows the result of a multi-functionalization 
experiment, after step 9 of FIG. 3b. The green fluorescently 
labelled PS strand sticks to the LS patterned region (letters of 
`materials' in FIG. 4c, left) by complementary DNA hybrid-
ization. Red streptavidin binds to the LS2-patterned biotin 
15 region (letters of `nature' in FIG. 4c, left). The distinct colors 
in separate filtering channels confirmed the successful pat-
terning of two different functions without interference. 
Pattern resolution was investigated in FIG. 5A, in which an 
inverted "U" shape was exposed to UV for different times, 
20 decorated with fluorescently labeled DNA and with colloids. 
Light intensity and particle concentration were analyzed for a 
cut through the two straight legs of the inverted "U". The dark 
black curves represent relative particle concentration. The 
last panel is the exposure profile. The light jagged shaped 
25 curves give the intensity of green fluorescent light from con-
focal images, and the corresponding smooth curves are a 
linear rescaling of the exposed peaks based on estimated 
coverage (from left to right: 8%, 15%, 28%, and 48%). The 
images and curves show that short exposure times (5 s) led to 
30 weak fluorescent light, and non-uniformity in colloidal pat-
tern (FIG. 5A, left) due to inhomogenous crosslinking 
Increasing exposure time yielded a stronger fluorescent sig-
nal and complete colloidal patterning, but also lowered the 
pattern resolution by producing undesired crosslinking in 
35 peripheral regions (FIG. 5A, right). Given that the litho-
graphic system was quite basic, —10 s exposure time was 
found to give a good balance between uniform functionaliza-
tion and high resolution. 
FIG. 5B shows the best resolution achieved by superim- 
40 posing the pattern image on the colloid and fluorescent 
images, respectively. The line width is —1.5 µm in the expo-
sure pattern and —2 µm in the fluorescent image, which sug-
gests at least 1 µm resolution on the edge. This resolution is 
slightly lower than standard UV photolithography in vacuum 
45 (-0.8 µm) or direct laser writing due to the presence of buffer. 
However, the results are within the parameters for use in DNA 
chips for gene identification or colloidal self-assembly. 
Example 4 
50 
Use of Cinnamate Crosslinking in Assembly 
To demonstrate the use of the present compositions and 
methods in assembly of structures, a pair of cinnamate 
55 nucleosides is inserted into the middle of two short Watson-
Crick complementary sequencs which are then positioned as 
surface nucleic acides on a substrate selected from the group 
consisting of nanoparticles, emulsion droplets, and photonic 
or plasmodic particles. The covalent crosslinking is activated 
6o by UV exposure. It is then possible to selectively and perma-
nently link the assembled constructs, including nano-particle 
crystals, aggregates from emulsion droplets, and photonic/ 
plasmodic structures. Once the assembled construct is 
covalently linked, the bonds are uninfluenced by factors like 
65 temperature and buffer condition. Cinnamate crosslinking of 
plasmodic structures in stability in dehydrated condition, a 
useful feature in fabricating solid state devices. 
US 9,2 57,171 B2 
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The foregoing description of illustrative embodiments has 	 are possible in light of the above teachings or may be acquired 
been presented for purposes of illustration and of description. 	 from practice of the disclosed embodiments. It is intended 
It is not intended to be exhaustive or limiting with respect to 	 that the scope of the invention be defined by the claims 
the precise form disclosed, and modifications and variations 	 appended hereto and their equivalents. 
SEQUENCE LISTING 
<160> NUMBER OF SEQ ID NOS: 9 
<210> SEQ ID NO 1 
<211> LENGTH: 61 
<212> TYPE: DNA 
<213> ORGANISM: Artificial Sequence 
<220> FEATURE: 
<223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic 
oligonucleotide 
<220> FEATURE: 
<221> NAME/KEY: misc_feature 
<222> LOCATION: (56)..(57) 
<223> OTHER INFORMATION: Nucleotides at these positions are separated 
by crosslinker 
<220> FEATURE: 
<223> OTHER INFORMATION: See specification as filed for detailed 
description of substitutions and preferred embodiments 
<400> SEQUENCE: 1 
atcgctaccc ttcgcacagt caatccagag agccctgcct ttcattacga ccaagttatg 	 60 
a 
	 61 
<210> SEQ ID NO 2 
<211> LENGTH: 61 
<212> TYPE: DNA 
<213> ORGANISM: Artificial Sequence 
<220> FEATURE: 
<223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic 
oligonucleotide 
<220> FEATURE: 
<221> NAME/KEY: misc_feature 
<222> LOCATION: (55)..(56) 
<223> OTHER INFORMATION: Nucleotides at these positions are separated by 
crosslinker 
<220> FEATURE: 
<223> OTHER INFORMATION: See specification as filed for detailed 
description of substitutions and preferred embodiments 
<400> SEQUENCE: 2 
atcgctaccc ttcgcacagt caatccagag agccctgcct ttcattacga tcataacttg 	 60 
g 	 61 
<210> SEQ ID NO 3 
<211> LENGTH: 50 
<212> TYPE: DNA 
<213> ORGANISM: Artificial Sequence 
<220> FEATURE: 
<223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic 
oligonucleotide 
<400> SEQUENCE: 3 
tcgtaatgaa aggcagggct ctctggattg actgtgcgaa gggtagcgat 	 50 
<210> SEQ ID NO 4 
<211> LENGTH: 40 
<212> TYPE: DNA 
<213> ORGANISM: Artificial Sequence 
<220> FEATURE: 
<223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic 
oligonucleotide 
<220> FEATURE: 
<221> NAME/KEY: misc_feature 
<222> LOCATION: (20)..(21) 
<223> OTHER INFORMATION: Nucleotides at these positions are separated by 
US 9,267,171 B2 
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20 
-continued 
crosslinker 
<220> FEATURE: 
<223> OTHER INFORMATION: See specification as filed for detailed 
description of substitutions and preferred embodiments 
<400> SEQUENCE: 4 
gctacccttc gcacagtcaa tccagagagc cctgcctttc 	 40 
<210> SEQ ID NO 5 
<211> LENGTH: 40 
<212> TYPE: DNA 
<213> ORGANISM: Artificial Sequence 
<220> FEATURE: 
<223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic 
oligonucleotide 
<220> FEATURE: 
<221> NAME/KEY: misc_feature 
<222> LOCATION: (20)..(21) 
<223> OTHER INFORMATION: Nucleotides at these positions are separated by 
crosslinker 
<220> FEATURE: 
<223> OTHER INFORMATION: See specification as filed for detailed 
description of substitutions and preferred embodiments 
<400> SEQUENCE: 5 
gaaaggcagg gctctctgga ttgactgtgc gaagggtagc 	 40 
<210> SEQ ID NO 6 
<211> LENGTH: 72 
<212> TYPE: DNA 
<213> ORGANISM: Artificial Sequence 
<220> FEATURE: 
<223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic 
oligonucleotide 
<220> FEATURE: 
<221> NAME/KEY: modified base 
<222> LOCATION: (1)..(50) 
<223> OTHER INFORMATION: a, c, t, g, unknown or other 
<220> FEATURE: 
<221> NAME/KEY: misc_feature 
<222> LOCATION: (61)..(62) 
<223> OTHER INFORMATION: Nucleotides at these positions are separated by 
cinnamate crosslinker 
<220> FEATURE: 
<223> OTHER INFORMATION: See specification as filed for detailed 
description of substitutions and preferred embodiments 
<400> SEQUENCE: 6 
nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn ttgagaaatg 	 60 
ccgtaaagag tt 
	
72 
<210> SEQ ID NO 7 
<211> LENGTH: 61 
<212> TYPE: DNA 
<213> ORGANISM: Artificial Sequence 
<220> FEATURE: 
<223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic 
oligonucleotide 
<220> FEATURE: 
<221> NAME/KEY: modified base 
<222> LOCATION: (12)..(61) 
<223> OTHER INFORMATION: a, c, t, g, unknown or other 
<220> FEATURE: 
<223> OTHER INFORMATION: 3 1 -BiotinTEG 
<400> SEQUENCE: 7 
ggatgaagat gnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn 	 60 
n 	 61 
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22 
-continued 
<210> SEQ ID NO 8 
<211> LENGTH: 33 
<212> TYPE: DNA 
<213> ORGANISM: Artificial Sequence 
<220> FEATURE: 
<223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic 
oligonucleotide 
<220> FEATURE: 
<221> NAME/KEY: misc_feature 
<222> LOCATION: (22)..(23) 
<223> OTHER INFORMATION: Nucleotides at these positions are separated by 
cinnamate crosslinker 
<220> FEATURE: 
<223> OTHER INFORMATION: See specification as filed for detailed 
description of substitutions and preferred embodiments 
<400> SEQUENCE: 8 
catcttcatc caactcttta cggcatttct caa 	 33 
<210> SEQ ID NO 9 
<211> LENGTH: 49 
<212> TYPE: DNA 
<213> ORGANISM: Artificial Sequence 
<220> FEATURE: 
<223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic 
oligonucleotide 
<400> SEQUENCE: 9 
cgtaatgaaa ggcagggctc tctggattga ctgtgcgaag ggtagcgat 	 49 
What is claimed is: 
1. A composition comprising: 
a first substrate having a first surface nucleic acid strand 
comprising a first cinnamate functional group and form-
ing a first sticky end, 
a second substrate having a second surface nucleic acid 
strand comprising a second cinnamate functional group 
and forming a second sticky end, the first sticky end and 
the second sticky end substantially complementary and 
hybridizable with each other; 
wherein the first substrate and the second substrate are 
covalently bonded via the first cinnamate functional 
group and the second cinnamate functional group. 
2. The composition of claim 1, wherein the substrate is 
selected from the group consisting of a membrane, glass, 
plastic, bead, emulsion droplet, nanoparticle, or photonic/ 
plasmonic structure, and is solid, semi-solid, fibrous, capil-
lary or porous.  
30 
3. The composition of claim 1, wherein the covalent bond-
ing is the result of a hybridization step and a subsequent UV 
exposure step. 
4. The composition of claim 3, wherein the hybridization 
35 step takes place as a result of a heating step. 
5. The composition of claim 1, wherein the 5' end of the 
nucleic acid strand is connected to a tetraethylene glycol 
spacer terminated by a biotin group. 
6. The composition of claim 1, wherein the sticky end has 
4o 
a sequence of 5'-TACG-linker-CGTA-3' and the linker is cin-
namate. 
7. The composition of claim 3, wherein the UV exposure 
takes place for less than 30 minutes. 
8. The composition of claim 3, wherein the UV exposure 
45 takes place for less than 15 seconds at an intensity of about 3.6 
mW/cm3. 
